$ADMP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adamis Pharmaceuticals Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adamis Pharmaceuticals Corp. Get notifications about new insider transactions in Adamis Pharmaceuticals Corp for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2015 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Senior VP of Bus. D ... | Sell | S | 6.18 | 7,000 | 43,260 | 164,473 | 171.5 K to 164.5 K (-4.08 %) |
Dec 31 2014 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Sell | S | 6.09 | 12,228 | 74,469 | 171,473 | 183.7 K to 171.5 K (-6.66 %) |
Dec 31 2014 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Senior VP of Bus. D ... | Sell | S | 6.00 | 772 | 4,632 | 183,701 | 184.5 K to 183.7 K (-0.42 %) |
Dec 15 2014 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Sell | S | 5.18 | 4,000 | 20,739 | 184,473 | 188.5 K to 184.5 K (-2.12 %) |
Nov 10 2014 | CLGY | Adamis Pharmaceuti ... | DENBY WILLIAM C | Director | Option Exercise | A | 4.14 | 20,000 | 82,800 | 20,000 | |
Nov 10 2014 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Option Exercise | A | 4.14 | 20,000 | 82,800 | 20,000 | |
Nov 10 2014 | CLGY | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 4.14 | 20,000 | 82,800 | 20,000 | |
Sep 26 2014 | CLGY | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 4.56 | 47,058 | 214,584 | 50,000 | |
Sep 26 2014 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Option Exercise | A | 4.56 | 47,058 | 214,584 | 50,000 | |
Sep 26 2014 | CLGY | Adamis Pharmaceuti ... | DENBY WILLIAM C | Director | Option Exercise | A | 4.56 | 47,058 | 214,584 | 50,000 | |
Sep 04 2014 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Sell | S | 5.06 | 8,000 | 40,472 | 188,473 | 196.5 K to 188.5 K (-4.07 %) |
Sep 03 2014 | CLGY | Adamis Pharmaceuti ... | DENBY WILLIAM C | Director | Buy | P | 5.06 | 2,500 | 12,642 | 2,500 | 0 to 2.5 K |
Sep 02 2014 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Buy | P | 4.03 | 5,500 | 22,165 | 20,000 | 14.5 K to 20 K (+37.93 %) |
Aug 27 2014 | CLGY | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 4.04 | 2,942 | 11,886 | 2,942 | |
Aug 27 2014 | CLGY | Adamis Pharmaceuti ... | DENBY WILLIAM C | Director | Option Exercise | A | 4.04 | 2,942 | 11,886 | 2,942 | |
Aug 27 2014 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Option Exercise | A | 4.04 | 2,942 | 11,886 | 2,942 | |
Jun 11 2014 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 5.24 | 26,585 | 139,372 | 1,715,388 | 1.7 M to 1.7 M (-1.53 %) |
Jun 04 2014 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Sell | S | 5.56 | 4,000 | 22,256 | 202,354 | 206.4 K to 202.4 K (-1.94 %) |
Apr 03 2014 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | A | 6.32 | 40,800 | 257,856 | 40,800 | |
Apr 03 2014 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | A | 6.32 | 8,200 | 51,824 | 8,200 | |
Apr 03 2014 | CLGY | Adamis Pharmaceuti ... | Moll Thomas | VP of Research | Option Exercise | A | 6.32 | 40,800 | 257,856 | 40,800 | |
Apr 03 2014 | CLGY | Adamis Pharmaceuti ... | Moll Thomas | VP of Research | Option Exercise | A | 6.32 | 8,200 | 51,824 | 8,200 | |
Apr 03 2014 | CLGY | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Option Exercise | A | 6.32 | 40,800 | 257,856 | 40,800 | |
Apr 03 2014 | CLGY | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Option Exercise | A | 6.32 | 8,200 | 51,824 | 8,200 | |
Apr 03 2014 | CLGY | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Option Exercise | A | 6.32 | 90,300 | 570,696 | 90,300 | |
Apr 03 2014 | CLGY | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Option Exercise | A | 6.32 | 45,200 | 285,664 | 45,200 | |
Apr 03 2014 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | SVP of Business Dev ... | Option Exercise | A | 6.32 | 45,200 | 285,664 | 45,200 | |
Apr 03 2014 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | SVP of Business Dev ... | Option Exercise | A | 6.32 | 13,600 | 85,952 | 13,600 | |
Oct 17 2013 | CLGY | Adamis Pharmaceuti ... | Nova Tina Susan | Director | Option Exercise | A | 0.36 | 35,000 | 12,600 | 35,000 | |
Oct 17 2013 | CLGY | Adamis Pharmaceuti ... | Cohen Kenneth M | Director | Option Exercise | A | 0.36 | 35,000 | 12,600 | 35,000 | |
Aug 05 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.57 | 56,000 | 31,993 | 29,660,555 | 29.7 M to 29.7 M (-0.19 %) |
Aug 05 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.57 | 11,960 | 6,808 | 29,716,555 | 29.7 M to 29.7 M (-0.04 %) |
Jul 31 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.56 | 28 | 16 | 29,728,515 | 29.7 M to 29.7 M (0.00 %) |
Jul 31 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.56 | 10,300 | 5,768 | 29,728,543 | 29.7 M to 29.7 M (-0.03 %) |
Aug 15 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.58 | 15 | 9 | 29,613,540 | 29.6 M to 29.6 M (0.00 %) |
Aug 15 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.57 | 7,000 | 3,990 | 29,613,555 | 29.6 M to 29.6 M (-0.02 %) |
Aug 08 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.56 | 15,000 | 8,333 | 29,620,555 | 29.6 M to 29.6 M (-0.05 %) |
Aug 08 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.56 | 25,000 | 14,000 | 29,635,555 | 29.7 M to 29.6 M (-0.08 %) |
Jul 26 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.56 | 25,000 | 14,000 | 29,738,843 | 29.8 M to 29.7 M (-0.08 %) |
Jul 26 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.56 | 32,900 | 18,424 | 29,763,843 | 29.8 M to 29.8 M (-0.11 %) |
Jul 26 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.56 | 32,100 | 17,976 | 29,796,743 | 29.8 M to 29.8 M (-0.11 %) |
Jul 26 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.60 | 5,000 | 3,000 | 29,828,843 | 29.8 M to 29.8 M (-0.02 %) |
Jul 24 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.59 | 24,900 | 14,691 | 29,833,843 | 29.9 M to 29.8 M (-0.08 %) |
Jul 24 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.58 | 5,000 | 2,900 | 29,858,743 | 29.9 M to 29.9 M (-0.02 %) |
Jul 24 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.56 | 66,000 | 36,960 | 29,863,743 | 29.9 M to 29.9 M (-0.22 %) |
Jul 24 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.56 | 10,324 | 5,781 | 29,929,743 | 29.9 M to 29.9 M (-0.03 %) |
Jul 24 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.56 | 10,000 | 5,601 | 29,940,067 | 30 M to 29.9 M (-0.03 %) |
Jul 24 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.60 | 5,000 | 3,000 | 29,950,067 | 30 M to 30 M (-0.02 %) |
Jul 24 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.60 | 20,000 | 12,012 | 29,955,067 | 30 M to 30 M (-0.07 %) |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Option Exercise | A | 0.67 | 535,982 | 359,108 | 535,982 | |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Grant | A | 0.00 | 111,828 | 0 | 8,054,206 | 7.9 M to 8.1 M (+1.41 %) |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Grant | A | 0.00 | 124,378 | 0 | 7,942,378 | 7.8 M to 7.9 M (+1.59 %) |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Moll Thomas | Vice President of R ... | Option Exercise | A | 0.67 | 187,594 | 125,688 | 187,594 | |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Moll Thomas | Vice President of R ... | Grant | A | 0.00 | 39,140 | 0 | 374,110 | 335 K to 374.1 K (+11.68 %) |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Moll Thomas | Vice President of R ... | Grant | A | 0.00 | 55,970 | 0 | 334,970 | 279 K to 335 K (+20.06 %) |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Johnson Craig A | Director | Grant | A | 0.00 | 22,575 | 0 | 22,575 | 0 to 22.6 K |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Nova Tina Susan | Director | Grant | A | 0.00 | 19,776 | 0 | 19,776 | 0 to 19.8 K |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Cohen Kenneth M | Director | Grant | A | 0.00 | 19,776 | 0 | 19,776 | 0 to 19.8 K |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Senior Vice Preside ... | Option Exercise | A | 0.67 | 267,991 | 179,554 | 267,991 | |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Senior Vice Preside ... | Grant | A | 0.00 | 55,914 | 0 | 3,508,007 | 3.5 M to 3.5 M (+1.62 %) |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Senior Vice Preside ... | Grant | A | 0.00 | 62,189 | 0 | 3,452,093 | 3.4 M to 3.5 M (+1.83 %) |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | A | 0.67 | 187,594 | 125,688 | 187,860 | |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Grant | A | 0.00 | 39,140 | 0 | 965,860 | 926.7 K to 965.9 K (+4.22 %) |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Grant | A | 0.00 | 55,970 | 0 | 926,720 | 870.8 K to 926.7 K (+6.43 %) |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Daniels Karen K. | Vice President of O ... | Option Exercise | A | 0.67 | 187,594 | 125,688 | 187,594 | |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Daniels Karen K. | Vice President of O ... | Grant | A | 0.00 | 39,140 | 0 | 108,110 | 69 K to 108.1 K (+56.75 %) |
Mar 12 2013 | CLGY | Adamis Pharmaceuti ... | Daniels Karen K. | Vice President of O ... | Grant | A | 0.00 | 55,970 | 0 | 68,970 | 13 K to 69 K (+430.54 %) |
Mar 05 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.80 | 4,575 | 3,660 | 29,975,067 | 30 M to 30 M (-0.02 %) |
Mar 01 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.80 | 6,678 | 5,316 | 29,979,642 | 30 M to 30 M (-0.02 %) |
Mar 01 2013 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 0.81 | 14,000 | 11,340 | 29,986,320 | 30 M to 30 M (-0.05 %) |
Oct 15 2012 | CLGY | Adamis Pharmaceuti ... | Nova Tina Susan | Director | Option Exercise | A | 0.75 | 35,000 | 26,250 | 35,000 | |
Oct 15 2012 | CLGY | Adamis Pharmaceuti ... | Cohen Kenneth M | Director | Option Exercise | A | 0.75 | 35,000 | 26,250 | 35,000 | |
Oct 15 2012 | CLGY | Adamis Pharmaceuti ... | Johnson Craig A | Director | Option Exercise | A | 0.75 | 35,000 | 26,250 | 35,000 | |
Sep 16 2011 | CLGY | Adamis Pharmaceuti ... | Moll Thomas | Vice President of R ... | Option Exercise | A | 0.19 | 300,000 | 57,000 | 300,000 | |
Sep 16 2011 | CLGY | Adamis Pharmaceuti ... | Daniels Karen K. | Vice President of O ... | Option Exercise | A | 0.19 | 300,000 | 57,000 | 300,000 | |
Sep 15 2011 | CLGY | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Option Exercise | A | 0.19 | 600,000 | 114,000 | 600,000 | |
Sep 15 2011 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | A | 0.19 | 125,000 | 23,750 | 125,000 | |
Sep 15 2011 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Senior Vice Preside ... | Option Exercise | A | 0.19 | 125,000 | 23,750 | 125,000 | |
Sep 15 2011 | CLGY | Adamis Pharmaceuti ... | Cohen Kenneth M | Director | Option Exercise | A | 0.18 | 35,000 | 6,300 | 35,000 | |
Sep 15 2011 | CLGY | Adamis Pharmaceuti ... | Johnson Craig A | Director | Option Exercise | A | 0.18 | 35,000 | 6,300 | 35,000 | |
Sep 15 2011 | CLGY | Adamis Pharmaceuti ... | Nova Tina Susan | Director | Option Exercise | A | 0.18 | 35,000 | 6,300 | 35,000 | |
Jul 05 2011 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Grant | A | 0.25 | 10,000,000 | 2,500,000 | 30,000,000 | 20 M to 30 M (+50.00 %) |
Feb 11 2011 | CLGY | Adamis Pharmaceuti ... | Nova Tina Susan | Director | Option Exercise | A | 0.20 | 50,000 | 10,000 | 50,000 | |
Feb 11 2011 | CLGY | Adamis Pharmaceuti ... | Johnson Craig A | Director | Option Exercise | A | 0.20 | 50,000 | 10,000 | 50,000 | |
Jan 18 2011 | CLGY | Adamis Pharmaceuti ... | Cohen Kenneth M | Director | Option Exercise | A | 0.21 | 50,000 | 10,500 | 50,000 | |
Sep 10 2010 | CLGY | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President/CEO | Option Exercise | P | 0.27 | 975,000 | 263,250 | 975,000 | |
Sep 10 2010 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | VP/Bus. Dev. & Inv. ... | Option Exercise | A | 0.27 | 550,000 | 148,500 | 550,000 | |
Sep 10 2010 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | A | 0.27 | 159,833 | 43,155 | 159,833 | |
Sep 10 2010 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | A | 0.27 | 500,000 | 135,000 | 500,000 | |
Apr 03 2009 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Option Exercise | A | 0.60 | 50,000 | 30,000 | 50,000 | |
Apr 03 2009 | CLGY | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 0.60 | 50,000 | 30,000 | 50,000 | |
Apr 08 2009 | CLGY | Adamis Pharmaceuti ... | ADAMS JOHN Q | Director | Option Exercise | A | 0.60 | 50,000 | 30,000 | 50,000 | |
Nov 13 2008 | CLGY | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | CEO | Option Exercise | S | 1,000.00 | 7,053,993 | 7,053,993,000 | 7,053,993 | |
Nov 13 2008 | CLGY | Adamis Pharmaceuti ... | GREGORY JOHN M | 10% Owner | Option Exercise | S | 0.00 | 7,053,993 | 705 | 7,053,993 | |
Dec 28 2006 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Sell | S | 1,100.00 | 20,000 | 22,000,000 | 0 | 20 K to 0 (-100.00 %) |
Dec 27 2006 | CLGY | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Director | Sell | S | 540.00 | 10,000 | 5,400,000 | 20,000 | 30 K to 20 K (-33.33 %) |
Dec 22 2006 | CLGY | Adamis Pharmaceuti ... | ADAMS JOHN Q | Director | Sell | S | 1,000.00 | 20,000 | 20,000,000 | 0 | 20 K to 0 (-100.00 %) |
Dec 22 2006 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Sell | S | 825.00 | 15,000 | 12,375,000 | 20,000 | 35 K to 20 K (-42.86 %) |
Nov 21 2005 | CLGY | Adamis Pharmaceuti ... | STEINBERG THOMAS M | Director | Option Exercise | A | 1.34 | 12,000 | 16,080 | 12,000 | |
Nov 21 2005 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Option Exercise | A | 1.34 | 12,000 | 16,080 | 12,000 | |
Nov 21 2005 | CLGY | Adamis Pharmaceuti ... | ADAMS JOHN Q | Director | Option Exercise | A | 1.34 | 12,000 | 16,080 | 12,000 | |
Nov 21 2005 | CLGY | Adamis Pharmaceuti ... | CHANDLER JOHN J | VP, Corporate Devel ... | Sell | S | 0.71 | 5,000 | 3,550 | 10,000 | 15 K to 10 K (-33.33 %) |
Nov 21 2005 | CLGY | Adamis Pharmaceuti ... | KLAR TOBI B | Director | Option Exercise | A | 1.34 | 12,000 | 16,080 | 12,000 | |
Jun 03 2005 | CLGY | Adamis Pharmaceuti ... | Corner Anne-Marie | Sr.VP, Women's Prev ... | Option Exercise | M | 0.06 | 10,277 | 617 | 0 | |
Jun 03 2005 | CLGY | Adamis Pharmaceuti ... | Corner Anne-Marie | Sr.VP, Women's Prev ... | Buy | M | 0.06 | 10,277 | 617 | 10,277 | 0 to 10.3 K |
Jun 21 2005 | CLGY | Adamis Pharmaceuti ... | Corner Anne-Marie | Senior Vice Preside ... | Option Exercise | A | 0.06 | 10,277 | 617 | 10,277 | |
May 16 2005 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Buy | P | 2.13 | 20,000 | 42,600 | 35,000 | 15 K to 35 K (+133.33 %) |
May 16 2005 | CLGY | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Interim CEO | Buy | P | 2.13 | 20,000 | 42,600 | 30,000 | 10 K to 30 K (+200.00 %) |
May 16 2005 | CLGY | Adamis Pharmaceuti ... | TISCH THOMAS J | 10% Owner | Option Exercise | A | 2.50 | 128,800 | 322,000 | 128,800 | |
May 16 2005 | CLGY | Adamis Pharmaceuti ... | TISCH THOMAS J | 10% Owner | Option Exercise | A | 2.25 | 128,800 | 289,800 | 128,800 | |
May 16 2005 | CLGY | Adamis Pharmaceuti ... | TISCH THOMAS J | 10% Owner | Buy | P | 0.00 | 644,000 | 0 | 899,422 | 255.4 K to 899.4 K (+252.13 %) |
May 16 2005 | CLGY | Adamis Pharmaceuti ... | GREGORY JOHN M | 10% Owner | Option Exercise | P | 2.50 | 45,000 | 112,500 | 45,000 | |
May 16 2005 | CLGY | Adamis Pharmaceuti ... | GREGORY JOHN M | 10% Owner | Option Exercise | P | 2.25 | 45,000 | 101,250 | 45,000 | |
May 16 2005 | CLGY | Adamis Pharmaceuti ... | GREGORY JOHN M | 10% Owner | Buy | P | 1.65 | 225,000 | 371,250 | 7,053,993 | 6.8 M to 7.1 M (+3.29 %) |
May 16 2005 | CLGY | Adamis Pharmaceuti ... | ADAMS JOHN Q | Director | Buy | P | 2.13 | 10,000 | 21,300 | 20,000 | 10 K to 20 K (+100.00 %) |
Apr 07 2005 | CLGY | Adamis Pharmaceuti ... | Caso Robert J | VP, Finance & CFO | Option Exercise | A | 1.75 | 100,000 | 175,000 | 100,000 | |
Mar 10 2005 | CLGY | Adamis Pharmaceuti ... | Corner Anne-Marie | Senior Vice Preside ... | Option Exercise | A | 2.03 | 150,000 | 304,500 | 150,000 | |
Dec 29 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | VP, Clinical Resear ... | Sell | S | 2.73 | 2,000 | 5,460 | 0 | 2 K to 0 (-100.00 %) |
Dec 28 2004 | CLGY | Adamis Pharmaceuti ... | CHANDLER JOHN J | VP, Corporate Devel ... | Sell | S | 2.63 | 3,200 | 8,416 | 15,000 | 18.2 K to 15 K (-17.58 %) |
Nov 08 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Option Exercise | M | 1.92 | 2,000 | 3,840 | 103,000 | |
Nov 08 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Buy | M | 1.92 | 2,000 | 3,840 | 2,000 | 0 to 2 K |
Nov 08 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 5.04 | 1,000 | 5,040 | 0 | 1,000 to 0 (-100.00 %) |
Nov 08 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 5.01 | 1,000 | 5,010 | 1,000 | 2 K to 1,000 (-50.00 %) |
Nov 08 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 4.99 | 2,000 | 9,980 | 2,000 | 4 K to 2 K (-50.00 %) |
Nov 08 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 5.00 | 1,000 | 5,000 | 4,000 | 5 K to 4 K (-20.00 %) |
Nov 08 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 5.07 | 1,000 | 5,070 | 5,000 | 6 K to 5 K (-16.67 %) |
Nov 05 2004 | CLGY | Adamis Pharmaceuti ... | JUELIS A RICHARD | Vice President | Sell | S | 5.05 | 2,600 | 13,130 | 6,820 | 9.4 K to 6.8 K (-27.60 %) |
Nov 05 2004 | CLGY | Adamis Pharmaceuti ... | JUELIS A RICHARD | Vice President | Sell | S | 4.97 | 9,100 | 45,227 | 9,420 | 18.5 K to 9.4 K (-49.14 %) |
Nov 05 2004 | CLGY | Adamis Pharmaceuti ... | JUELIS A RICHARD | Vice President | Sell | S | 4.90 | 500 | 2,450 | 18,520 | 19 K to 18.5 K (-2.63 %) |
Nov 05 2004 | CLGY | Adamis Pharmaceuti ... | JUELIS A RICHARD | Vice President | Sell | S | 4.95 | 9,000 | 44,550 | 19,020 | 28 K to 19 K (-32.12 %) |
Nov 05 2004 | CLGY | Adamis Pharmaceuti ... | JUELIS A RICHARD | Vice President | Sell | S | 4.92 | 5,500 | 27,060 | 28,020 | 33.5 K to 28 K (-16.41 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | JUELIS A RICHARD | Vice President | Sell | S | 4.70 | 600 | 2,820 | 33,520 | 34.1 K to 33.5 K (-1.76 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | JUELIS A RICHARD | Vice President | Sell | S | 4.76 | 100 | 476 | 33,520 | 33.6 K to 33.5 K (-0.30 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | JUELIS A RICHARD | Vice President | Sell | S | 4.80 | 100 | 480 | 33,520 | 33.6 K to 33.5 K (-0.30 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | JUELIS A RICHARD | Vice President | Sell | S | 4.82 | 100 | 482 | 33,520 | 33.6 K to 33.5 K (-0.30 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | JUELIS A RICHARD | Vice President | Sell | S | 4.87 | 100 | 487 | 33,520 | 33.6 K to 33.5 K (-0.30 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | JUELIS A RICHARD | Vice President | Sell | S | 4.86 | 100 | 486 | 33,520 | 33.6 K to 33.5 K (-0.30 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | JUELIS A RICHARD | Vice President | Sell | S | 4.90 | 600 | 2,940 | 33,520 | 34.1 K to 33.5 K (-1.76 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | JUELIS A RICHARD | Vice President | Sell | S | 4.91 | 100 | 491 | 33,520 | 33.6 K to 33.5 K (-0.30 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 4.99 | 2,000 | 9,980 | 6,000 | 8 K to 6 K (-25.00 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 4.98 | 1,000 | 4,980 | 8,000 | 9 K to 8 K (-11.11 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 4.90 | 2,000 | 9,800 | 9,000 | 11 K to 9 K (-18.18 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 4.83 | 1,000 | 4,830 | 11,000 | 12 K to 11 K (-8.33 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 4.87 | 2,000 | 9,740 | 12,000 | 14 K to 12 K (-14.29 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 4.84 | 5,000 | 24,200 | 14,000 | 19 K to 14 K (-26.32 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 4.85 | 1,000 | 4,850 | 19,000 | 20 K to 19 K (-5.00 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 5.17 | 2,500 | 12,925 | 20,000 | 22.5 K to 20 K (-11.11 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 5.00 | 1,000 | 5,000 | 20,000 | 21 K to 20 K (-4.76 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 4.95 | 1,000 | 4,950 | 20,000 | 21 K to 20 K (-4.76 %) |
Nov 04 2004 | CLGY | Adamis Pharmaceuti ... | KARLIN DAVID A | Vice President | Sell | S | 4.90 | 1,000 | 4,900 | 20,000 | 21 K to 20 K (-4.76 %) |